Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer
NCT05505812
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
BIOLOGICAL:
HS-IT101
Sponsor
The Affiliated Hospital of Qingdao University
Collaborators
[object Object]